Which is good.
But nonetheless it was a poor move.
I strongly recommend all holders move to remove the board and CEO. There is no further benefit to gain.
- Forums
- ASX - By Stock
- DRO
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-97
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DRO (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.58 |
Change
0.240(10.3%) |
Mkt cap ! $1.914B |
Open | High | Low | Value | Volume |
$2.41 | $2.60 | $2.41 | $45.43M | 18.05M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7559 | $2.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.38 | 869 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 133188 | 2.570 |
13 | 137422 | 2.560 |
21 | 208914 | 2.550 |
10 | 111235 | 2.540 |
5 | 50147 | 2.530 |
Price($) | Vol. | No. |
---|---|---|
2.580 | 34190 | 6 |
2.590 | 80419 | 14 |
2.600 | 173361 | 44 |
2.610 | 51024 | 10 |
2.620 | 28012 | 5 |
Last trade - 15.59pm 15/07/2024 (20 minute delay) ? |
Featured News
DRO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online